UDK: 616.12-008.331+616.12-008.46-039-085.224
I.N. Tyurenkov, A.V. Nazvanova, N.G. Chepurina
Кафедра фармакологии и биофармации ФУВ, лаборатория фармакологии сердечно-сосудистых средств НИИ фармакологии
The revealed hypotensive effect of oral ultralow doses (ULD) of antibodies to receptor type 1 ATII (cardos) in spontaneously hypertensive rats is a good foundation for a new class of hypotensive drugs. The detected hypotensive effect of ULD antibodies to components of renin-angiotensin system (RAS) may be due to modulating impacts of antibodies on the RAS. A significant decrease in systolic arterial blood pressure (SABP) was found in rats receiving cardos. Lozartan decreased SABP by 25 % and kept stable during the period of observation. ULD antibodies to receptor type 1 ATII (cardos) decreased SABP by 10 %. This hypotensive effect is of great interest in regard to developing original medicinal preparations of a new generation.
ultralow doses antibodies, cardos, lozartan, spontaneously hypertensive rats
Тюренков Иван Николаевич – д.м.н., профессор, зав. кафедрой фармакологии и биофармации ФУВ ВолГМУ, fibfuv@vistcom.ru